James Gould

James Gould

March 28, 2019 | The Legal Intelligencer

Guidance Regarding a Standing Requirement for IPR Appeals in 2 Recent Pharma Cases

Thanks to recent decisions by the U.S. Court of Appeals for the Federal Circuit (CAFC), we have clarity that both requirements must be met to appeal an adverse final written decision issued during that IPR, and we also have some guidance as to how these requirements will be determined in such cases.

By James Gould

8 minute read